Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-26 · accession 0001231589-25-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-11-26 | 2025-11-26 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $486.07 | -11.0K | 45.5K | -19% | -$5.35M |
| DT | 2025-11-26 | 2025-11-26 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $135.42 | +11.0K | 47.8K | +30% | +$1.49M |
| DT | 2025-11-26 | 2025-11-26 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -11.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-26 | S | D | 2,210 | $485.15 | 43,331 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $484.75 to $485.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-11-26 | S | D | 3,350 | $487.21 | 38,058 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $486.76 to $487.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2025-11-26 | S | D | 1,277 | $488.13 | 36,781 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $487.79 to $488.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2025-11-26 | M | A | 11,000 | $135.42 | 47,781 | D | — | — | |
| 5 | Common | Common Stock | 2025-11-26 | S | D | 1,923 | $486.23 | 41,408 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $485.75 to $486.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2025-11-26 | S | D | 513 | $483.05 | 47,268 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $482.53 to $483.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2025-11-26 | S | D | 1,727 | $484.20 | 45,541 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $483.71 to $484.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Derivative | Stock Option | 2025-11-26 | M | D | 11,000 | $0.00 | 0 | D | $135.42 · 2023-03-15 to 2027-03-15 | 11,000 Common Stock |